Search for a trial

Immunogenicity of HPV-vaccination in a reduced-dose schedule

To study the kinetics of the vaccine-induced antibody response against HPV16/18 after a two-dose schedule by measuring these antibody responses at approximately 7, 12, 24, 36, 48, 60, 72, 84, 96, 108 and 120 months following the first dose of HPV-…

Cost-effectiveness of lifestyle care tailored to pregnant women with obesity during this critical period and window of opportunity in the life course: The HYGEIA randomised controlled trial.

Main objective is to assess the effectiveness of SP+ in an almost real-life setting of a randomised controlled trial (RCT) in 930 women with obesity, using CVMD-score as primary outcome measurement. Secondary aim is to assess the cost-effectiveness…